Kalium Health, a company pioneering new technology to transform chronic disease management,
has been awarded grant funding by Innovate UK, the UK's innovation agency. The funding will provide invaluable support to drive further advancements in the company's blood sensing capabilities.
Innovate UK's A4I program aims to connect businesses with leading scientific facilities and expertise to overcome technical challenges and drive innovation across various sectors. Kalium Health's selection for the highly competitive grant further validates its innovative vision and commitment to transforming the healthcare landscape.
As part of their ongoing commitment to collaboration and knowledge exchange, Kalium Health has forged a strategic partnership with the National Physical Laboratory (NPL). The A4I grant will facilitate this collaboration, enabling Kalium Health to tap into NPL's diverse expertise and benefit from their specialist facilities and world-class manufacturing expertise.
"We are extremely honoured to be awarded the A4I grant from Innovate UK," said Prof. Tanya Hutter, Chief Technology Officer of Kalium Health. "This grant will significantly enhance our capabilities to develop our technology aimed at improving patient outcomes and healthcare efficiency. With the support of Innovate UK, we are confident in our ability to advance our pipeline of technical innovation and make a lasting impact on the healthcare industry."
Kalium Health specialises in developing advanced technologies that leverage real-time blood sensing, data analytics and clinical innovation to enable new modes of patient monitoring and improve the management of chronic diseases. Their innovative solutions are designed to empower healthcare providers and patients alike, enabling better decision-making, personalised treatments, and ultimately, improved health outcomes at reduced cost.
Innovate UK's recognition of Kalium Health's potential highlights the company's position as a pioneer in the healthcare technology sector. By successfully securing this grant funding, Kalium Health further solidifies its commitment to innovation and positions itself as a catalyst for positive change within chronic disease management.
Innovate UK
Innovate UK drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base. With a strong business focus, they drive growth by working with companies to de-risk, enable and support innovation.
They connect businesses to the partners, customers and investors that can help them turn ideas into commercially successful products and services leading to business growth. They fund business and research collaborations to accelerate innovation and drive business investment into research and development. Their support is available to businesses across all economic sectors, value chains and UK regions.
For more information, visit: www.innovateuk.ukri.org
Kalium Health
Kalium Health is transforming the way that chronic disease are managed for millions of people living with kidney disease or heart disease. They are developing a range of products based on innovative technology for the very low cost, accurate detection of electrolyte levels in small amounts of blood.
Electrolyte imbalances, experienced by those with kidney disease, can lead to illness and sudden death. Similarly, commons medications for heart disease can also lead to dangerous high potassium levels.
Kalium Health’s technology will enable life-saving monitored by patients themselves without having to travel to a clinic for an invasive blood test.
Kalium Health spun out of the University of Cambridge in 2019 with backing from Cambridge Enterprise, Kidney Research UK, Martlet Capital and leading life science investors. With an expert team of scientists and engineers, the company is headquartered in the UK with a presence in the USA.
For more information, visit: www.kaliumhealth.com or contact hello@kaliumhealth.com